Plain-English translation of NCT03022552 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at NYU are studying how tiny blood cells called platelets behave during and after a heart attack. By comparing blood samples from people who've had a heart attack to those without heart disease, they hope to understand why some people have heart attacks even without severely blocked arteries, and why others with blocked arteries don't. This research could help doctors better predict and prevent future heart attacks.
Currently, doctors don't fully understand why some people suffer heart attacks without obvious artery blockages, or what role platelets play in heart attacks. This study aims to fill that gap so treatment and prevention can be more targeted and effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll have blood drawn at two time points: once during your heart catheterization procedure (when the doctor looks at your heart arteries) and again 2 months later. The blood samples will be analyzed in the lab to study how your platelets function and their genetic makeup. The entire study commitment is relatively brief, with the main work happening during a procedure you'd likely have anyway.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
NYU Langone Health
Enrollment target
~350 participants
Started
July 2020
Primary completion
June 2027
Age range
21 Years – 99 Years
Sex
Female only
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jeffrey Berger, MD
NYU Langone Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.